Current language:
Current country:

The No. 1 probotic drug worldwide

Biocodex is an independent, global pharmaceutical company that was founded in 1953 in France by Michel Hublot and François Vallet. Biocodex was originally created for the production and marketing of Saccharomyces boulardii, a unique probiotic drug. Since then, Biocodex has expanded its range by developing more of its own products, as well as redeveloping products acquired from other companies. Biocodex now specializes in several therapeutic areas: Gastroenterology, Neurology, Psychiatry and Pain Treatment.
Today Biocodex strives to develop safe and effective products that improve the patient's health and quality of life. Biocodex makes sure that its products are available to the doctors and patients who need them. The company's progress relies on a commitment to the service of its patients and a close-knit relationship with doctors, pharmacists, and hospitals. Biocodex works towards the long term, while constantly improving its products with a clear and focused mindset. There are a total of 8 Biocodex offices stationed worldwide, with 3 sites in France and 5 subsidiary locations around the world. Today, Biocodex products are available in more than 100 countries around the world.